Oregon, the latest state to tackle high drug prices, pushes through transparency law
fiercepharma | March 14, 2018
Pharma has suffered another defeat in the state-by-state war over drug prices. On Tuesday, Oregon Gov. Kate Brown signed a bill that seeks to fight high costs and bring transparency to pharmaceutical pricing. Oregon's HB 4005 requires drugmakers to report R&D and marketing costs, profits and more for drugs that get price hikes of more than 10%, according to a release from the group behind the bill, Oregonians for Affordable Drug Prices Now. Companies must also report whether generics are available and certain drug prices in other countries, the group says.